In addition, METTL16 can inhibit the translation of DVL2 mRNA through m6A modification, thereby regulating the Wnt/β-catenin signalling pathway and inhibiting the proliferation of pancreatic ductal adenocarcinoma cells [45]. This evidence concerns the gene METTL16 and pancreatic ductal adenocarcinoma.